ALX ONCOLOGY HOLDINGS INC

ALXO

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093913
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock option (right to buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+700,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

700,000.0

Filing's footnotes

1. One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.